145 related articles for article (PubMed ID: 10613341)
1. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials.
Bacus JW; Boone CW; Bacus JV; Follen M; Kelloff GJ; Kagan V; Lippman SM
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1087-94. PubMed ID: 10613341
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine.
Poulin N; Boiko I; MacAulay C; Boone C; Nishioka K; Hittelman W; Mitchell MF
Cytometry; 1999 Oct; 38(5):214-23. PubMed ID: 10516607
[TBL] [Abstract][Full Text] [Related]
3. DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia.
Boiko IV; Mitchell MF; Pandey DK; White RA; Hu W; Malpica A; Nishioka K; Boone CW; Atkinson EN; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):849-55. PubMed ID: 9332769
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Boiko IV; Mitchell MF; Hu W; Pandey DK; Mathevet P; Malpica A; Hittelman WN
Clin Cancer Res; 1998 Jun; 4(6):1383-91. PubMed ID: 9626454
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
[TBL] [Abstract][Full Text] [Related]
6. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image- and flow cytometry.
Ruiz A; Almenar S; Callaghan RC; Llombart-Bosch A
Pathol Res Pract; 1999; 195(11):741-6. PubMed ID: 10605693
[TBL] [Abstract][Full Text] [Related]
7. Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors.
Ruiz A; Almenar S; Cerdá M; Hidalgo JJ; Puchades A; Llombart-Bosch A
Breast J; 2002; 8(3):139-44. PubMed ID: 12047469
[TBL] [Abstract][Full Text] [Related]
8. [Study on nuclear DNA content and image cytometry in cervical cancer and precursor lesions].
Jiao Y; Zhou X; Ma S
Zhonghua Fu Chan Ke Za Zhi; 2001 May; 36(5):267-70. PubMed ID: 11783373
[TBL] [Abstract][Full Text] [Related]
9. Mean nuclear volume in cervical intraepithelial neoplasia and carcinoma.
Dey P; Powari M
Anal Quant Cytol Histol; 2002 Apr; 24(2):70-2. PubMed ID: 12026052
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.
Chapman JA; Miller NA; Lickley HL; Qian J; Christens-Barry WA; Fu Y; Yuan Y; Axelrod DE
BMC Cancer; 2007 Sep; 7():174. PubMed ID: 17845726
[TBL] [Abstract][Full Text] [Related]
11. Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture.
Drezek R; Guillaud M; Collier T; Boiko I; Malpica A; Macaulay C; Follen M; Richards-Kortum R
J Biomed Opt; 2003 Jan; 8(1):7-16. PubMed ID: 12542374
[TBL] [Abstract][Full Text] [Related]
12. Grading of ductal breast carcinoma by cytomorphology and image morphometry with histologic correlation.
Tahlan A; Nijhawan R; Joshi K
Anal Quant Cytol Histol; 2000 Jun; 22(3):193-8. PubMed ID: 10872034
[TBL] [Abstract][Full Text] [Related]
13. Nuclear DNA content analysis by static cytometry in cervical intraepithelial lesions using retrospective series of previously stained PAP smears.
Shirata NK; Gomes NS; Garcia EA; Longatto Filho A
Adv Clin Path; 2001 Jul; 5(3):87-91. PubMed ID: 11753880
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of nuclear grading assessed by image cytometry for node negative breast cancer patients.
Kimijima I; Watanabe T; Abe R
Anticancer Res; 1996; 16(6C):3949-53. PubMed ID: 9042318
[TBL] [Abstract][Full Text] [Related]
15. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
16. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and prognostic use of DNA-Image-Cytometry in cervical squamous intraepithelial lesions and invasive carcinoma].
Sun XR; Wang J; Boecking A
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):435-7. PubMed ID: 16251055
[No Abstract] [Full Text] [Related]
18. Quantitative study of ductal breast cancer progression. Morphometric evaluation of phenotypical changes occurring in benign and preinvasive epithelial lesions.
Mariuzzi GM; Mariuzzi L; Mombello A; Santinelli A; Valli M; Rahal D; Thompson D; Bartels PH
Pathol Res Pract; 1994 Nov; 190(11):1056-65. PubMed ID: 7746739
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia.
Monsonego J; Valensi P; Zerat L; Clavel C; Birembaut P
Br J Obstet Gynaecol; 1997 Jun; 104(6):723-7. PubMed ID: 9197877
[TBL] [Abstract][Full Text] [Related]
20. Morphometric evaluation of nucleolar organizer regions in cervical intraepithelial neoplasia.
Sakai YI; Sakai AT; Isotani S; Cavaliere MJ; de Almeida LV; Calore EE
Pathol Res Pract; 2001; 197(3):189-92. PubMed ID: 11314783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
